Corbus Pharmaceuticals Holdings (CRBP) Free Cash Flow (2013 - 2025)

Corbus Pharmaceuticals Holdings' Free Cash Flow history runs 13 years deep, the most recent figure standing at -$15.6 million for Q3 2025.

• In Q3 2025, Free Cash Flow fell 11.53% year-over-year to -$15.6 million; the TTM figure through Dec 2025 stood at -$48.6 million (down 16.21% YoY), while the FY2024 annual figure was -$41.8 million, down 15.77% from the prior year.
• Free Cash Flow was -$15.6 million for Q3 2025 at Corbus Pharmaceuticals Holdings, up from -$16.6 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $856954.0 in Q3 2021 to a low of -$21.8 million in Q1 2021.
• Historically, Free Cash Flow has averaged -$11.2 million across 5 years, with a median of -$10.6 million in 2022.
• The sharpest annual moves came in 2021 and 2022: Free Cash Flow surged 103.14% in 2021, then slumped 945.44% in 2022.
• A 5-year view of Free Cash Flow shows it stood at -$9.8 million in 2021, then gained by 23.59% to -$7.5 million in 2022, then increased by 19.41% to -$6.0 million in 2023, then slumped by 82.12% to -$10.9 million in 2024, then slumped by 42.11% to -$15.6 million in 2025.
• The last three Free Cash Flow figures came in at -$15.6 million (Q3 2025), -$16.6 million (Q2 2025), and -$16.4 million (Q1 2025), per Business Quant data.